Core Viewpoint - Yifan Pharmaceutical has made progress in its long-term strategy of "integration, innovation, and internationalization" since 2016, particularly in globalizing its pharmaceutical products and enhancing its sales and risk resistance capabilities [2] Group 1: Company Achievements - The company has seen a year-on-year increase in sales of its proprietary pharmaceutical products since 2020, indicating a positive trend in revenue growth [2] - In the past two years, the revenue from the company's innovative drug products has continued to expand, which is expected to significantly improve the quality of future profits [2]